GQG Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140M | Sell |
3,025,192
-8,998,262
| -75% | -$417M | 0.2% | 53 |
|
|
2025
Q1 | $733M | Buy |
12,023,454
+11,970,598
| +22,648% | +$730M | 1.17% | 29 |
|
|
2024
Q4 | $2.99M | Buy |
+52,856
| New | +$2.99M | ﹤0.01% | 81 |
|
|
2023
Q2 | – | Sell |
-42,232
| Closed | -$2.93M | – | 72 |
|
|
2023
Q1 | $2.93M | Sell |
42,232
-471,183
| -92% | -$32.7M | 0.01% | 67 |
|
|
2022
Q4 | $36.9M | Buy |
513,415
+51,365
| +11% | +$3.7M | 0.1% | 50 |
|
|
2022
Q3 | $32.9M | Sell |
462,050
-1,015,421
| -69% | -$72.3M | 0.1% | 47 |
|
|
2022
Q2 | $114M | Buy |
1,477,471
+871,872
| +144% | +$67.2M | 0.28% | 42 |
|
|
2022
Q1 | $44.2M | Buy |
+605,599
| New | +$44.2M | 0.1% | 45 |
|
|
2021
Q4 | – | Sell |
-17,071
| Closed | -$1.01M | – | 87 |
|
|
2021
Q3 | $1.01M | Sell |
17,071
-154
| -0.9% | -$9.11K | ﹤0.01% | 59 |
|
|
2021
Q2 | $1.15M | Buy |
17,225
+6,856
| +66% | +$458K | ﹤0.01% | 53 |
|
|
2021
Q1 | $655K | Sell |
10,369
-4,483,454
| -100% | -$283M | ﹤0.01% | 55 |
|
|
2020
Q4 | $279M | Buy |
4,493,823
+3,783,133
| +532% | +$235M | 0.96% | 36 |
|
|
2020
Q3 | $42.8M | Sell |
710,690
-3,044,997
| -81% | -$184M | 0.15% | 52 |
|
|
2020
Q2 | $221M | Buy |
+3,755,687
| New | +$221M | 0.97% | 34 |
|